BCWORLD PHARM (A200780) Stock Overview
Operates as a pharmaceutical company in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 1/6 |
A200780 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
BCWORLD PHARM. Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,109.09 |
| 52 Week High | ₩5,309.09 |
| 52 Week Low | ₩3,827.27 |
| Beta | 0.73 |
| 1 Month Change | 23.38% |
| 3 Month Change | 24.06% |
| 1 Year Change | 20.09% |
| 3 Year Change | -27.01% |
| 5 Year Change | -73.81% |
| Change since IPO | -53.12% |
Recent News & Updates
Recent updates
BCWORLD PHARM. Co., Ltd.'s (KOSDAQ:200780) Popularity With Investors Is Under Threat From Overpricing
Dec 12
Revenues Not Telling The Story For BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780) After Shares Rise 30%
Jan 03Does BCWORLD PHARM (KOSDAQ:200780) Have A Healthy Balance Sheet?
Dec 04Investors Shouldn't Be Too Comfortable With BCWORLD PHARM's (KOSDAQ:200780) Earnings
Mar 18BCWORLD PHARM (KOSDAQ:200780) Seems To Be Using A Lot Of Debt
Mar 01Does The Market Have A Low Tolerance For BCWORLD PHARM. Co., Ltd.'s (KOSDAQ:200780) Mixed Fundamentals?
Feb 09
Is BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780) A Good Dividend Stock?
Jan 25If You Had Bought BCWorld Pharm (KOSDAQ:200780) Stock A Year Ago, You Could Pocket A 75% Gain Today
Jan 11Do Insiders Own Lots Of Shares In BCWorld Pharm Co., Ltd. (KOSDAQ:200780)?
Dec 26Are BCWorld Pharm's (KOSDAQ:200780) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 08Is BCWorld Pharm (KOSDAQ:200780) A Risky Investment?
Nov 18Shareholder Returns
| A200780 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.9% | -3.1% | 2.6% |
| 1Y | 20.1% | 27.0% | 67.8% |
Return vs Industry: A200780 underperformed the KR Pharmaceuticals industry which returned 27% over the past year.
Return vs Market: A200780 underperformed the KR Market which returned 67.8% over the past year.
Price Volatility
| A200780 volatility | |
|---|---|
| A200780 Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A200780 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A200780's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 271 | Steve Hong | www.bcwp.co.kr |
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM.
BCWORLD PHARM. Co., Ltd. Fundamentals Summary
| A200780 fundamental statistics | |
|---|---|
| Market cap | ₩47.42b |
| Earnings (TTM) | -₩3.76b |
| Revenue (TTM) | ₩77.04b |
Is A200780 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A200780 income statement (TTM) | |
|---|---|
| Revenue | ₩77.04b |
| Cost of Revenue | ₩45.85b |
| Gross Profit | ₩31.19b |
| Other Expenses | ₩34.96b |
| Earnings | -₩3.76b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -405.55 |
| Gross Margin | 40.49% |
| Net Profit Margin | -4.89% |
| Debt/Equity Ratio | 120.6% |
How did A200780 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/28 10:42 |
| End of Day Share Price | 2025/12/26 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BCWORLD PHARM. Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.